Newswise — Christopher Dixon, M.D., Assistant Professor of Urology at New York University School of Medicine, whose clinical practice is devoted to men with benign prostatic hyperplasia, is available to comment on the ramifications of a landmark study on the medical treatment of this common condition. The study, to be published in the New England Journal of Medicine on Dec. 18, is embargoed for release at 5 p.m. Eastern Time on Wednesday, Dec. 17.
The study involved 17 centers nationwide, including NYU Medical Center. Dr. Dixon was the lead investigator at NYU, and he was involved in the initial planning of the overall trial. He can discuss how this study's findings will influence medical practice.
RSS